Related Experiment Video
Updated: Feb 27, 2026
06:08
Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions
Published on: March 8, 2019
20.9K
Non-coding RNA Contribution to Thoracic and Abdominal Aortic Aneurysm Disease Development and Progression
Yuhuang Li1, Lars Maegdefessel1,2
1Vascular Biology Unit, Department of Vascular and Endovascular Surgery, Klinikum rechts der Isar der Technical University of MunichMunich, Germany.
Frontiers in Physiology
|July 4, 2017
Summary
Non-coding RNAs (ncRNAs) are crucial regulators in cardiovascular homeostasis and aneurysm development. Targeting these molecules offers promising therapeutic and biomarker strategies for aortic aneurysms.
Area of Science:
- Cardiovascular biology
- Molecular genetics
- RNA biology
Background:
- Cardiovascular homeostasis relies on complex genetic and epigenetic regulation.
- Non-coding RNAs (ncRNAs) play a significant role in gene expression and cardiovascular health.
- Aortic aneurysms involve progressive vessel dilation, inflammation, and extracellular matrix dysregulation, with no current conservative treatments.
Purpose of the Study:
- To review current findings on ncRNAs in aortic aneurysm progression.
- To explore novel concepts for utilizing ncRNAs in therapeutic and biomarker applications.
Main Methods:
- Literature review of research on ncRNAs and aortic aneurysms.
- Analysis of ncRNA involvement in gene regulation and aneurysm pathology.
- Discussion of antisense oligonucleotide strategies for therapeutic targeting.
Main Results:
- Several ncRNAs, particularly microRNAs, have been identified as key players in aortic aneurysm progression.
- ncRNAs regulate gene expression critical for vascular smooth muscle cell function and extracellular matrix dynamics.
- Dysregulation of ncRNAs contributes to the pathological processes underlying aneurysm formation and expansion.
Conclusions:
- ncRNAs are significant regulators of cardiovascular homeostasis and are implicated in aortic aneurysm development.
- Targeting ncRNAs presents a promising avenue for developing novel pharmacological therapies and diagnostic biomarkers for aortic aneurysms.
- Future research focusing on ncRNA-based strategies could lead to improved patient outcomes for aortic aneurysms.
Related Concept Videos
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
433
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
433
02:39lncRNA - Long Non-coding RNAs
10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
01:30Aneurysm I: Introduction
554
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
554
01:30Coronary Artery Disease I: Introduction
1.3K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
01:32RNA Splicing
61.0K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.0K
02:18Alternative RNA Splicing
25.4K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.4K